Consumer Driven Health Care

The plaintiff wants to represent a class of enrollees who suffer from the 'disability' of obesity.

Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal blood sugar.

While the ruling does not derail the Medicare drug negotiation program, which drugmakers have already agreed to prices for the first 10 drugs selected for the first round, it sends the case back to a lower court for consideration.

The PBMs say out-of-pocket insulin costs have fallen sharply since 2019.

Nearly 3 in 4 employed Americans would accept a job with a slightly lower salary if it offered better health care and medical coverage.

"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed," said Rahul Rao, deputy director of the FTC's Bureau of Competition.